1[1]Gridelli C.Chemotherapy of non-small cell lung cancer in the elderly[J].Lung Cancer,2002,38(Suppl 3):S67-S70.
2[2]Ricci S,Antonuzzo A,Galli L,et al.Gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer:A multicenter phase Ⅱ study[J].Lung Cancer,2000,27(2):75-80.
3[3]Laack E,Mende T,Benk J,et al.Gemcitabine and vinorelbine as first-line chemotherapy for advanced nonsmall cell lung cancer:a phase Ⅱ trial[J].Eur J Cancer,2001,37(5):583-590.
4[4]Baron F,Cueva J,Grana B,et al.Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer[J].Eur J Cancer,2001,37(11):1381-1384.
5[5]Gridelli C,Cigolari S,Gallo C,et al.Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase Ⅱ data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial[J].Lung Cancer,2001,31(2-3):277-284.
6[6]Chen YM,Perng RP,Chen MC,et al.A phase Ⅱ trial of vinorelbine plus gemcitabine in previously untreated inoperable(stage Ⅲb/Ⅳ) non-small-cell lung cancer patients aged 80 or older[J].Lung Cancer,2003,40(2):221-226.
同被引文献6
1BARON F, CUEVA J, GRANA B, et al. Gemeitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer [J]. Eur J Cancer, 2001, 37(11) :1381-1384.
2CHEN Y M, PERNG R P, CHEN M C, etal. A plase Ⅱ trial of vinorelbine plus gemcitabine in previously untreated inoperable(stage Ⅲb/Ⅳ) non-small-cell lung cancer patients aged 80 or older[J]. Lung Cancer,2003, 40(2) :221-226.
3Baron F,Cueva J,Grana B,et al . Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer [J].Eur J Cancer, 2001, 37(11):1381-1384.
4Chen YM, Perng RP, Chen MC, et al.A plase II trial of vinorelbine plus gemcitabine in previously untreated inoperable(stage Ⅲ b/Ⅳ) non-small-cell lung cancer patients aged 80 or older[J]. Lung Cancer,2003, 40(2):221-226.
5Chen YM,Peng RP,Chen MC,et al.A plase Ⅱ trail of vinorelbine plus gemcitabine in previously untreated inoperable(stage Ⅲ b/Ⅳ)non-small-cell lung cancer patients aged 80 or older[J].Lung Cancer,2003,40(2):221-226.
